Effects of 13-HODE and other momohydroxides on integrin/ligand binding: implications for cell cell interactions.
Buchanan
M R
MR
Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Brister
S J
SJ
D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002450:Cell Communication / Q000187:drug effects / Q000502:physiology; D004337:Drug Carriers; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D005340:Fibrinogen / Q000378:metabolism*; D005353:Fibronectins / Q000378:metabolism*; D006893:Hydroxyeicosatetraenoic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D007700:Kinetics; D008041:Linoleic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D008081:Liposomes; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000187:drug effects / Q000502:physiology*; D019030:Receptors, Vitronectin / Q000187:drug effects / Q000502:physiology*; D019096:Vitronectin / Q000378:metabolism*
D004337:Drug Carriers; D005353:Fibronectins; D006893:Hydroxyeicosatetraenoic Acids; D008041:Linoleic Acids; D008081:Liposomes; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D019030:Receptors, Vitronectin; D019096:Vitronectin; C024348:13-hydroxy-9,11-octadecadienoic acid; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid; D005340:Fibrinogen